Publications
52
Citations
404
Est. group size
~16
Recurring co-author estimate
Active years
9
Publishing since 2018
Elizabeth M. Muhowski's research focuses on blood cancers (such as leukemia and lymphoma) and the cellular signaling pathways involved in their development and treatment, including studies of immune cells like T cells and their role in cancer immunotherapy. Recent work explores how specific proteins affect the effectiveness of immune-based cancer treatments, such as anti-PD-1 immunotherapy, using mouse models and single-cell analysis techniques.
Publication output was low and variable in the earlier part of the decade but increased sharply starting in 2023, suggesting a recent period of growing research activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- 490 Aak1 inhibition diminishes efficacy of anti-PD-1 immunotherapy in murine tumor models
Regular and Young Investigator Award Abstracts · 2024
- Dual TCR-Expressing T Cells in Cancer: How Single-Cell Technologies Enable New Investigation
ImmunoHorizons · 2023
- Blood×6
- Cancer Discovery×2
- Blood Advances×1
- Cancer Research Communications×1
- Journal of Hematology & Oncology×1
- Jazmin Urrutia
Medicine · The Ohio State University
- Janani Ravikrishnan
Medicine · The Ohio State University
- Andrew D. Mitchell
Medicine · The Ohio State University
- Alexander Marr
Medicine · The Ohio State University
- Samon Benrashid
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile